APA (7th ed.) Citation

Xiang Xiao, Xiang Xiao, Xiang Xiao, Junlin Zhang, Junlin Zhang, Shuming Ji, . . . Fang Liu. (2022). Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Xiang Xiao, et al. Intravitreal Vascular Endothelial Growth Factor Inhibitors Did Not Increase the Risk of End-stage Renal Disease in Patients with Biopsy-proven Diabetic Kidney Disease Based on Matched Study. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Xiang Xiao, et al. Intravitreal Vascular Endothelial Growth Factor Inhibitors Did Not Increase the Risk of End-stage Renal Disease in Patients with Biopsy-proven Diabetic Kidney Disease Based on Matched Study. Frontiers Media S.A., 2022.